1
PFO ACCESS Registry
Condition(s): Patent Foramen Ovale; Stroke Last Updated: January 23, 2013Available
81 Clinical Trials for: “Expanded Access”, Recruiting Open, Page 1 of 5
Include Studies Not Seeking New Volunteers
2
Uridine Triacetate as an Antidote for Patients at Excess Risk of 5-Fluorouracil (5-FU) Toxicity Due to Overdosage or Impaired Elimination
Condition(s): Toxicity Due to Chemotherapy; Impaired 5FU Elimination Last Updated: March 20, 2012Available
3
Compassionate Use of Triheptanoin (C7) for Fatty Acid Oxidation Disorders
Condition(s): Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency; Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2); Mitochondrial Trifunctional Protein Deficiency; Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency Last Updated: July 19, 2012Available
4
Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
Condition(s): Multiple Myeloma Last Updated: November 30, 2010Available
5
Bivalirudin foR Acute Myocardial Infarction underGoing Angioplasty in CHinese patienTs.
Condition(s): Acute Myocardial Infarction Last Updated: April 8, 2013Available
6
Comparison Study of Adjuvant Chemotherapy for Chinese Triple Negative Breast Cancer
Condition(s): Triple Negative Breast Cancer Last Updated: October 6, 2010Available
7
Compassionate Use of the Becker Expander/Breast Implant
Condition(s): Breast Reconstruction Last Updated: April 12, 2013Available
8
To Validate the Specific Patterns of Magnetocardiography, a Non-invasive Non-contact Examination for Patients With Ischemic Heart Disease or Cardiac Arrhythmia
Condition(s): Arrhythmia Last Updated: December 20, 2012Available
9
Compassionate Use of Stiripentol in Dravet Syndrome
Condition(s): Dravet Syndrome Last Updated: April 29, 2013Available
10
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
Condition(s): Diabetes; CVD Last Updated: December 20, 2012Available
11
Use of Eylea for the Treatment of an Optic Nerve Hemangioma
Condition(s): Retinal Hemangioma Last Updated: October 22, 2012Available
12
Effects of High-intensity Interval Training in Patients in Hemodialysis
Condition(s): Chronic Renal Disease; Hemodialysis Last Updated: January 8, 2013Available
13
Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
Condition(s): Lambert-Eaton Myasthenic Syndrome Last Updated: February 22, 2011Available
14
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Condition(s): Liver Cancer Last Updated: January 18, 2013Available
15
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Condition(s): Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Myelodysplastic Syndrome; Lymphomas; Bone Marrow Failure; Hemoglobinopathy; Immune Deficiency; Osteopetrosis; Cytopenias; White Blood Cell Abnormalities; Red Blood Cell Abnormalities Last Updated: May 16, 2013Available
16
Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
Condition(s): Graft vs Host Disease; Graft-Versus-Host Disease Last Updated: October 10, 2012Available
17
An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Condition(s): Malignant Solid Tumour; Breast Cancer; Ovarian Cancer; Colorectal Cancer Last Updated: April 30, 2013Available
18
Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition(s): Post-transplant Recurrent Hepatitis C Last Updated: January 29, 2013Available
19
An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory
Condition(s): Metastatic Breast Cancer Last Updated: March 3, 2013Available
20
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition(s): Diabetes Mellitus, Type 1 Last Updated: February 7, 2013Available
